Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 85, Issue 5, 1996, Pages 917-922

  Caner, Hakan H ^a   Kwan, Aij Lie ^c   Arthur, Adam ^c   Jeng, Arco Y ^c   Lappe, Rodney W ^c   Kassell, Neal F ^c   Lee, Kevin S ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NONE

Author keywords

cerebral vasospasm; endothelin; endothelin converting enzyme; subarachnoid hemorrhage

Indexed keywords

2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID; CGS 24592; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VASOSPASM; CONTROLLED STUDY; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RABBIT; SUBARACHNOID HEMORRHAGE; TOPICAL DRUG ADMINISTRATION;

EID: 0029832067     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.5.0917     Document Type: Article

References (44)

1. Barone FC, Globus MYT, Price WJ, et al: Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 14:337-342, 1994
2. Clozel M, Breu V, Burri K, et al: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761, 1993
3. Clozel M, Watanabe H: BQ-123, a peptidic endothelin ET receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834, 1993
4. A - receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22 (Suppl 8): S332-S335, 1993
5. De Lombaert S, Ghai RD, Jeng AY, et al: Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Biophys Res Commun 204:407-412, 1994
6. Ehrenreich H, Lange M, Near KA, et al: Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with sub-arachnoid hemorrhage. Res Exp Med 192:257-268, 1992
7. Fadel MM, Foley PL, Kassell NF, et al: Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg Neurol 43:52-57, 1995
8. Feger GI, Schilling L, Ehrenreich H, et al: Endothelin-induced contraction and relaxation of rat isolated basilar artery: effect of BQ-123. J Cereb Blood Flow Metab 14:845-852, 1994
9. Foley PL, Caner HH, Kassell NF, et al: Reversal of subarachoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 34:108-113, 1994
10. Fujimori A, Yanagisawa M, Saito A, et al: Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 336:633, 1990 (Letter)
11. Gaetani P, Rodriguez y Baena R, Grignani G, et al: Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 57:66-72, 1994
12. Hino A, Weir BKA, Macdonald RL, et al: Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83:503-509, 1995
13. Inoue A, Yanagisawa M, Kimura S, et al: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867, 1989
14. Inoue A, Yanagisawa M, Takuwa Y, et al: The human preproendothelin 1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 264:14954-14959, 1989
15. A receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 81:759-764, 1994
16. A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195:969-975, 1993
17. Kasuya H, Weir BKA, White DM, et al: Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg 79: 892-898, 1993
18. Kobayashi H, Hayashi M, Kobayashi S, et al: Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 28:673-679, 1991
19. Kobayashi H, Hayashi M, Kobayashi S, et al: Effect of endothelin on the canine basilar artery. Neurosurgery 27:357-361, 1990
20. Kraus G, Bucholz RD, Yoon KW, et al: Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review. Surg Neurol 35:20-29, 1991
21. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991
22. Matsumura Y, Ikegawa R, Suzuki Y, et al: Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 49:841-848, 1991
23. Matsumura Y, Ikegawa R, Tsukahara Y, et al: Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett 272:166-170, 1990
24. A receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52:1869-1874, 1993
25. Ohlstein EH, Storer BL: Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77: 274-278, 1992
26. Opgenorth TJ, Wu-Wong JR, Shiosaki K: Endothelin-converting enzymes. FASEB J 6:2653-2659, 1992
27. Roux S, Löffler BM, Gray GA, et al: The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37:78-86, 1995
28. Rubanyi GM, Polokoff MA: Endothelins: molecular biology, biohemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415, 1994
29. Seifert V, Löffler BM, Zimmermann M, et al: Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62, 1995
30. Shigeno T, Mima T, Yanagisawa M, et al: Possible role of endothelin in the pathogenesis of cerebral vasospasm. J Cardiovasc Pharmacol 17 (Suppl 7):S480-S483, 1991
31. Shinyama H, Uchida T, Kido H, et al: Phosphoramidon inhibits the conversion of intracisternally administered big endothelin-1 to endothelin-1. Biochem Biophys Res Commun 178:24-30, 1991
32. Shirakami G, Magaribuchi T, Shingu K, et al: Changes of endothelin concentration in cerebrospinal fluid and plasma of patients with aneurysmal subarachnoid hemorrhage. Acta Anaesthesiol Scand 38:457-461, 1994
33. Suzuki H, Sato S, Suzuki Y, et al: Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 81:553-554, 1990
34. Suzuki R, Masaoka H, Hirata Y, et al: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96-100, 1992
35. Umemura K, Ishiye M, Kosuge K, et al: Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model. Eur J Pharmacol 275:17-21, 1995
36. Warner TD, Battistini B, Doherty AM, et al: Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol 48:625-635, 1994
37. Willette RN, Zhang H, Mitchell MP, et al: Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 25:2450-2456, 1994
38. Wilson C, Hargreaves RB: Inhibition of the pharmacological effects of endothelin. Prog Med Chem 31:371-410, 1994
39. Yamaji T, Johshita H, Ishibashi M, et al: Endothelin family in human plasma and cerebrospinal fluid. J Clin Endocrinol Metab 71:1611-1615, 1990
40. Yamaura I, Tani E, Maeda Y, et al: Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 76:99-105, 1992
41. Yanagisawa M, Inoue A, Ishikawa T, et al: Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85:6964-6967, 1988
42. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
43. Ziv I, Fleminger G, Djaldetti R, et al: Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23:1014-1016, 1992
44. B receptors in subarachnoid hemorrhage-induced cerebral vasospasm. Eur J Pharmacol 259:R1-R2, 1994